BDBM725056 3-(tert-butyl)-N-((5R)-2-(2- (2,2-difluorocyclopropane-1- carboxamido)pyridin-4-yl)- 6,7,8,9-tetrahydro-5H- benzo[7]annulen-5-yl)-1,2,4- oxadiazole-5-carboxamide::US12240838, Compound 58

SMILES CC(C)(C)c1noc(C(=O)N[C@@H]2CCCCc3cc(-c4ccnc(NC(=O)C5CC5(F)F)c4)ccc32)n1

InChI Key InChIKey=GLJVSIGLJDBERN-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 725056   

TargetTyrosine-protein kinase BTK(Human)
Biogen Ma

US Patent
LigandPNGBDBM725056(3-(tert-butyl)-N-((5R)-2-(2- (2,2-difluorocyclopro...)
Affinity DataIC50: 1nMAssay Description:The purpose of the BTK in vitro assay is to determine compound potency against BTK through the measurement of IC50. Compound inhibition is measured a...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/6/2025
Entry Details
Go to US Patent